Life-sciences patent mid-levels lead live San Diego associate briefs. First, third-to-sixth-year patent prosecution and IP associates who can own claim sets without a long ramp. Second, biotech corporate associates next to venture and strategic financings. Third, technology and data-privacy associates who hold product and clinical-data work. Fourth, employment associates paired to growth-company headcount. Fifth, litigation associates with commercial or IP concentration where Southern District of California dockets make diligence cleaner.
NALP’s May 2026 Bulletin on 2025 lateral hiring still shows associates at 58.2% of all U.S. lateral hires, with West/Rocky Mountain overall laterals up 20.8%. Public 2025–2026 moves—Goodwin reopening San Diego with a patents co-chair from Wilson Sonsini, Latham’s High Bluff life-sciences work, Cooley and Pillsbury pricing the same biotech corridor—match our San Diego mandate telemetry on the 23 closed associate and counsel searches of the last three years: roughly 61% life-sciences or IP single mid-levels, about 22% corporate or technology singles, about 13% counsel seats, and only one multi-seat surge build.
Live confidential work typically includes Am Law 50–100 single mid-level patent and biotech adds, one-seat technology laterals for national firms deepening Torrey Pines coverage, and disputes associates for company-side dockets. Candidate-side interest is highest among associates whose tickets have outgrown current staffing credit, who need special-bonus protection, or who face a conflicts wall another firm can clear. Absolute volume is selective; ticket underwriting still decides who actually moves.